Cross-Sector entity

Medibank

Company MPL.AX
7

regulation is the sole category represented across all 2 tracked stories. CHOICE is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. We currently track 2 Cross-Sector stories that mention Medibank, all published on March 19, 2026.

2 verified stories tracked

Last mentioned: Mar 19, 2026

Entity pulse

Recent coverage · Medibank

2 stories
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Medibank

regulation is the sole category represented across all 2 tracked stories. CHOICE is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. We currently track 2 Cross-Sector stories that mention Medibank, all published on March 19, 2026. Each carries 9 original sources on average.

Stories tracked
2
Sources per story
9

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Medibank. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Implementation Deadline

    Standard date for annual premium increases to take effect across the industry.

  2. Ministerial Review Period

    Federal Health Minister begins reviewing fund submissions for premium adjustments.

  3. CHOICE Warning Issued

    Consumer group CHOICE flags massive 25% premium hikes across major funds.

Stories mentioning Medibank 2

Finance regulation Negative 7

Australian Health Insurance Premiums Set for 25% Surge, CHOICE Warns

Consumer advocacy group CHOICE has reported that major Australian health insurance funds are seeking or projecting premium increases of up to 25%. This unprecedented jump, pending regulatory approval, represents a significant cost-of-living pressure and could trigger a mass exodus of policyholders from private cover.

9 sources